Gastrointestinal Radiology: Page 7

PCCT's performance comparable to MRI for assessing hepatic steatosis

By Kate Madden Yee

Noncontrast photon-counting CT (PCCT) performs just as well as MRI when it comes to assessing hepatic steatosis, according to a study published February 8 in the European Journal of Radiology.

February 13, 2023

Can MRI radiomics help predict rectal cancer treatment response?

By Amerigo Allegretto

An MRI radiomics-based nomogram can outperform radiologists in predicting complete pathological response to neoadjuvant chemotherapy in locally advanced rectal cancer, a Chinese study published February 2 in Academic Radiology found.

February 7, 2023

3D-printed models improve pediatric retroperitoneal surgery planning

By Kate Madden Yee

Using 3D-printed models of retroperitoneal tumors is an effective way to plan surgery for children and to communicate about the procedure with their parents, according to a study published January 30 in Nature: Scientific Reports.

January 31, 2023

Fewer movements on ultrasound are just fine for pancreatic biopsy

By Amerigo Allegretto

Making fewer to-and-fro movements may be just fine for endoscopic ultrasound-guided fine-needle biopsy for solid pancreatic tumors, a study published January 24 in Gastrointestinal Endoscopy found.

January 24, 2023

PSMA-PET matches MRI, beats CT in diagnosing liver cancer

By Will Morton

Prostate-specific membrane antigen (PSMA) PET/CT appears equivalent to MRI and better than CT in diagnosing liver tumors in patients undergoing surveillance imaging, according to a group of Australian researchers.

January 22, 2023

MRI guidance beats CT for prostate cancer stereotactic body radiotherapy

By Kate Madden Yee

MRI-guided stereotactic body radiotherapy outperforms CT guidance when it comes to reducing toxic effects of the treatment, according to a study published January 12 in JAMA Oncology.

January 12, 2023

CECT helps assess liver cancer treatment response

By Kate Madden Yee

Contrast-enhanced CT (CECT) can help assess response to intra-arterial treatment in patients with neuroendocrine liver metastases and predict survival outcomes, according to a study published on January 6 in Radiology: Imaging Cancer.

January 9, 2023

Photon-counting CT just as good as MRI for quantifying liver fat

By Kate Madden Yee

Photon-counting CT (PCCT) performs just as well as MRI for quantifying liver fat in obese patients and can enable opportunistic screening for fatty liver disease, according to research results delivered at the recent RSNA meeting in Chicago.

December 27, 2022

Ascelia touts MRI contrast agent study

By AuntMinnie.com staff writers

Ascelia Pharma is highlighting results from a study presented at the RSNA meeting in Chicago that shows the effect of food intake on the absorption and signal intensity of its manganese-based MRI contrast agent for liver indications, Orviglance.

December 18, 2022

Fast acquisition techniques cut SPECT/CT bone scan times by half

By Will Morton

Whole-body SPECT/CT bone scan times to detect metastatic tumors in prostate cancer patients could be cut by half with the use of faster acquisition techniques, according to a study published December 12 in EJNMMI Physics.

December 18, 2022

PCCT reduces abdominal imaging radiation dose by almost 20%

By Kate Madden Yee

Photon-counting CT (PCCT) not only improves image quality for arterial phase abdominal scans compared to conventional CT, but it also reduces radiation dose by almost 20%, according to research presented at the 2022 RSNA meeting.

December 15, 2022

Olympus expands distribution agreement with EndoClot Plus

By AuntMinnie.com staff writers

Olympus has inked an exclusive distribution agreement with EndoClot Plus that extends the two firms' strategic partnership to the Europe, Middle East and Africa region.

December 7, 2022

Previous Page

Page 7 of 170

Next Page